![Sodium (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F313605-sodium-6r-7r-7-2z-2-5-amino-124-thiadiazol-3-yl-2-hydroxyimino-acetyl-amino-3-e-3r-1-5-methyl-2-oxo-13-dioxol-4-yl-methoxy-carbonyl-2-oxo-13-bipyrrolidin-3-ylidene-methyl-8-oxo-5-thia-1-azabicyclo-4-2-0-oct-2-ene-2-carboxylate-1-1.webp&w=3840&q=75)
CAS 252188-71-9: Sódio (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-tiadiazol-3-il)-2-(hidroximino)acetil]amino]-3-[(E)-[(3′R)-1′-[[(5-metil-2-oxo-1,3-dioxol-4-il)metoxi]carbonil]-2-oxo[1,3′-bipirrolidin]-3-ilideno]metil]-8-oxo-5-tia-1-azabiciclo[4.2.0]oct-2-eno-2-carboxilato (1:1)
Descrição:
A substância química conhecida como Sódio (6R,7R)-7-[[[2Z]-2-(5-amino-1,2,4-tiadiazol-3-il)-2-(hidroxiimino)acetil]amino]-3-[(E)-[(3′R)-1′-[[(5-metil-2-oxo-1,3-dioxol-4-il)metoxi]carbonilo]-2-oxo[1,3′-bipirrolidina]-3-ilideno]metil]-8-oxo-5-tia-1-azabiciclo[4.2.0]oct-2-eno-2-carboxilato (1:1) é um composto orgânico complexo caracterizado por sua estrutura intrincada, que inclui múltiplos grupos funcionais como amino, hidroxiimino e carboxilato. Este composto apresenta uma estrutura central bicíclica, indicativa de sua potencial atividade biológica. A presença de um anel de tiadiazole sugere possíveis propriedades antimicrobianas, enquanto os grupos oxo e dioxol podem contribuir para sua reatividade e estabilidade. Como sal de sódio, é provável que seja solúvel em água, o que pode aumentar sua biodisponibilidade para aplicações farmacêuticas. A estereoquímica específica do composto, denotada pela configuração (6R,7R), pode influenciar sua interação com alvos biológicos, tornando-o um tema de interesse em química medicinal e desenvolvimento de medicamentos. No geral, esta substância exemplifica a complexidade e diversidade dos compostos orgânicos sintéticos modernos usados em contextos terapêuticos.
Fórmula:C26H26N8O11S2·Na
InChI:InChI=1S/C26H26N8O11S2.Na/c1-10-14(45-26(41)44-10)8-43-25(40)32-4-3-13(7-32)33-5-2-11(20(33)36)6-12-9-46-22-16(21(37)34(22)17(12)23(38)39)28-19(35)15(30-42)18-29-24(27)47-31-18;/h6,13,16,22,42H,2-5,7-9H2,1H3,(H,28,35)(H,38,39)(H2,27,29,31);/b11-6+,30-15-;/t13-,16-,22-;/m1./s1
Chave InChI:InChIKey=BYUIXTXYXHAECA-LCJFHXTKSA-N
SMILES:C(O)(=O)C=1N2[C@@]([C@H](NC(/C(=N\O)/C=3N=C(N)SN3)=O)C2=O)(SCC1/C=C\4/C(=O)N(CC4)[C@H]5CN(C(OCC=6OC(=O)OC6C)=O)CC5)[H].[Na]
Sinónimos:- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3′R)-1′-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-2-oxo[1,3′-bipyrrolidin]-3-ylidene]methyl]-8-oxo-, sodium salt (1:1), (6R,7R)-
- Ro 65-5788
- Sodium (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)acetyl]amino]-3-[(E)-[(3′R)-1′-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-2-oxo[1,3′-bipyrrolidin]-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (1:1)
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(5-amino-1,2,4-thiadiazol-3-yl)(hydroxyimino)acetyl]amino]-3-[(E)-[(3′R)-1′-[[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl]-2-oxo[1,3′-bipyrrolidin]-3-ylidene]methyl]-8-oxo-, monosodium salt, (6R,7R)-
- Sodium (6R,7R)-3-((E)-(1-((R)-1-(((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy)carbonyl)pyrrolidin-3-yl)-2-oxopyrrolidin-3-ylidene)methyl)-7-((Z)-2-(5-amin
- BAL 5788
- Ceftobiprole medocaril sodium
- Ceftobiprole Medocaril Sodium Sterile Powder
Ordenar por
2 produtos.
Ceftobiprole medocaril sodium
CAS:Ceftobiprole medocaril sodium is a broad-spectrum cephalosporin antibiotic, which is a synthetically derived prodrug of ceftobiprole. Upon administration, ceftobiprole medocaril is rapidly converted into its active form, ceftobiprole, by the body's endogenous esterases. The mode of action involves binding to penicillin-binding proteins (PBPs) in the bacterial cell wall, leading to the inhibition of cell wall synthesis and ultimately the death of the bacteria. This action is effective against a wide range of gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and penicillin-resistant Streptococcus pneumoniae. Ceftobiprole medocaril sodium is primarily used in the treatment of complex skin and soft tissue infections, as well as community-acquired and hospital-acquired pneumonia. Its broad-spectrum efficacy makes it a critical tool in environments where multi-drug resistant bacterial strains are prevalent. The development of ceftobiprole medocaril was driven by the urgent need for effective antibiotics against resistant pathogens, enabling it to play a vital role in modern infectious disease management and antimicrobial stewardship.Fórmula:C26H26N8O11S2NaPureza:Min. 95%Peso molecular:713.65 g/molCeftobiprole medocaril sodium
CAS:Ceftobiprole medocaril sodium (BAL5788) is a prodrug of broad-spectrum cephalosporin active against MRSA, VRSA, and resistant streptococci.Fórmula:C26H25N8NaO11S2Cor e Forma:SolidPeso molecular:712.64
